If you would like to learn more about future focusIR related events and roundtables, please submit your details here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSomero Regulatory News (SOM)

Share Price Information for Somero (SOM)

Share Price is delayed by 15 minutes
Get Live Data
182.50    -2.50 (-1.35%)
Bid:
180.00
Ask:
185.00
Spread: 5.00 (2.778%)
Market Cap: £94.49m
SOM Live PriceLast checked at - London Stock Exchange

Intraday Somero Share Chart

Trading Update

19 Jul 2022 07:00

RNS Number : 8731S
Somero Enterprises Inc.
19 July 2022
 

19 July 2022

Somero Enterprises, Inc.

("Somero" or "the Company")

 

Trading Update

Somero® is pleased to provide an update on trading ahead of its interim results announcement scheduled to be released on Wednesday, 7 September 2022.

Driven by positive momentum from a highly active US non-residential construction market, healthy market conditions and elevated activity levels in the European and Australian markets, Group trading in H1 2022 ended higher than the comparable H1 2021 period. 

 

As expected, H1 2022 trading in North America remained strong, increasing from H1 2021, reflective of customers with sizable workloads and project backlogs that extend well into 2023. The breadth and variety of project activity in the US translated to healthy take rates across the Somero product portfolio including continued, strong performance in the boomed screed category.

 

The European market was active during H1 2022, reflective of positive non-residential construction market conditions and a busy customer base with healthy, extended project backlogs. While H1 2022 trading in Europe was down compared to H1 2021, due largely to logistics challenges that delayed machine shipments, based on the H1 2022 momentum and activity levels alongside anticipated catch-up on shipment delays to start H2 2022, second half 2022 trading is anticipated to accelerate, and Europe is anticipated to contribute to full-year 2022 growth. 

 

H1 2022 trading in Australia was also strong, improving from H1 2021, reflecting similar positive market conditions as the US and Europe, in line with the expectation that the region will contribute meaningfully to 2022 growth. Trading in all other regions also fell in line with expectations, including in China where revenues were down compared to H1 2021 due to the previously announced reduced Company focus on the region and the severe impact of COVID restrictions. 

 

New products, including the SkyScreed®, the S-PS50 Laser Screed® and the Somero Broom+CureTM, contributed meaningfully to H1 2022 sales while the Company continues to make good progress in identifying opportunities to penetrate untapped market segments and with development of new solutions for customers.

 

During the first six months of 2022, the also Company made substantial progress with the Houghton, Michigan building expansion project anticipated to be completed by the end of Q3 2022 and with adding new personnel necessary to support future growth of the business, particularly in our primary US, Europe and Australian markets. 

 

While cognizant of the uncertain macro economic environment, the Board continues to anticipate healthy trading to continue in H2 2022, a view underpinned by direct feedback from customers in the US, Europe & Australian indicating high workloads and extended project backlogs. As such, the Board is pleased to confirm 2022 results are anticipated to fall in line with market expectations for revenues of approximately US$ 138.8m, EBITDA of approximately US$ 47.7m, and year-end cash of approximately US$ 39.9m.

 

 

This announcement contains inside information for the purposes of Article 7 of EU Regulation 596/2014 as retained as part of UK law by virtue of the European Union (Withdrawal) Act 2018 as amended. Upon the publication of this Announcement, this inside information is now considered to be in the public domain.

 

Enquiries:

 

Somero Enterprises, Inc. www.somero.com

Jack Cooney, CEO +1 239 210 6500

John Yuncza, President

Vincenzo LiCausi, CFO

Howard Hohmann, EVP Sales

 

finnCap Ltd (NOMAD and Broker)

Matt Goode (Corporate Finance) +44 (0)20 7220 0500

Kate Bannatyne (Corporate Finance)

Tim Redfern/Richard Chambers (ECM)

 

Alma PR (Financial PR Advisor) somero@almapr.co.uk

David Ison +44 (0)20 3405 0205

Pippa Crabtree

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
TSTBKFBKABKDAOD
Date   Source Headline
21st Mar 20137:00 amRNSDirector/PDMR Shareholding
20th Mar 20139:17 amRNSChange of Adviser
13th Mar 20137:00 amRNSAnnual Report and Notice of AGM
26th Feb 20137:00 amRNSFinal Results
3rd Jan 20134:06 pmRNSTrading Statement
7th Dec 201211:56 amRNSHolding(s) in Company
21st Nov 20125:21 pmRNSHolding(s) in Company
21st Aug 20127:00 amRNSHalf Yearly Report
24th Jul 20122:02 pmRNSHolding(s) in Company
24th Jul 20121:57 pmRNSHolding(s) in Company
24th Jul 20121:56 pmRNSHolding(s) in Company
20th Jul 201212:13 pmRNSHolding(s) in Company
17th Jul 20127:00 amRNSTrading Update
2nd Jul 20123:10 pmRNSHolding(s) in Company
22nd Jun 20124:40 pmRNSHolding(s) in Company
28th May 20124:39 pmRNSHolding(s) in Company
22nd May 201211:55 amRNSResult of AGM
8th May 201210:30 amRNSDirector/PDMR Shareholding
8th May 201210:25 amRNSDirector/PDMR Shareholding
23rd Apr 20126:09 pmRNSHolding(s) in Company
23rd Apr 20123:24 pmRNSHolding(s) in Company
20th Apr 20121:52 pmRNSHolding(s) in Company
19th Apr 20127:00 amRNSTrading Update
13th Apr 20123:03 pmRNSDirector/PDMR Shareholding
11th Apr 201210:34 amRNSHolding(s) in Company
11th Apr 201210:31 amRNSHolding(s) in Company
11th Apr 201210:25 amRNSHolding(s) in Company
11th Apr 20127:00 amRNSHolding(s) in Company
27th Mar 201211:27 amRNSAnnual report and notice of AGM
26th Mar 20127:00 amRNSAdviser change of name
13th Mar 20127:00 amRNSFinal Results
23rd Feb 201212:10 pmRNSHolding(s) in Company
31st Jan 20124:06 pmRNSHolding(s) in Company
20th Jan 20127:00 amRNSTrading Update
16th Sep 20117:00 amRNSDirector/PDMR Shareholding
24th Aug 20117:00 amRNSHalf Yearly Report
5th Aug 20117:00 amRNSTrading Update
28th Jun 20113:48 pmRNSResult of AGM
28th Jun 20117:00 amRNSAGM Statement
16th Jun 20119:47 amRNSAnnual Report and Notice of AGM
17th May 20117:02 amRNSFinal Results
27th Jan 20117:00 amRNSTrading Statement
17th Jan 20113:23 pmRNSHolding(s) in Company
30th Sep 20103:57 pmRNSHolding(s) in Company
30th Sep 20103:53 pmRNSHolding(s) in Company
17th Aug 20107:00 amRNSTrading update
29th Jun 20101:57 pmRNSResult of AGM
15th Jun 20104:16 pmRNSDirector/PDMR Shareholding
28th May 20107:00 amRNSAnnual Report and Notice of AGM
18th May 20107:00 amRNSFinal Results

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.